Skip to search formSkip to main contentSkip to account menu

Designer Drugs

Known as: Drugs, Designer, Customized Drugs, Drugs, Customized 
Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest… 
National Institutes of Health

Related topics

Related topics

11 relations

Narrower (2)

2,5-Dimethoxy-4-methylamphetamineEcstasy - drug
Drug DependenceDrug DesignDrug abuserDrug usage

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health
As part of an increasing worldwide use of designer drugs, recent use of compounds containing cathinones and synthetic… 
Review
2015
Review
2015
Ventral tegmental area dopamine revisited: effects of acute and repeated stress
Aversive events rapidly and potently excite certain dopamine neurons in the ventral tegmental area (VTA), promoting phasic… 
Highly Cited
2015
Highly Cited
2015
Gq-DREADD Selectively Initiates Glial Glutamate Release and Inhibits Cue-induced Cocaine Seeking
Review
2014
Review
2014
Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines
The abuse of synthetic psychoactive substances known as “designer drugs,” or “new psychoactive substances” (NPS), is increasing… 
Review
2014
Review
2014
Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in…
From November 2013 to May 2014, 19 newly distributed designer drugs were identified in 104 products in our ongoing survey of… 
Highly Cited
2010
Highly Cited
2010
Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass…
In recent years, a new class of designer drugs has appeared on the drugs of abuse market in many countries, namely, the so-called… 
Highly Cited
2010
Highly Cited
2010
Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.
Highly Cited
2009
Highly Cited
2009
Identification of a cannabinoid analog as a new type of designer drug in a herbal product.
A new type of designer drug, a cannabinoid analog (1), was found in a herbal product distributed on the illegal drug market in… 
Highly Cited
2007
Highly Cited
2007
The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.
Highly Cited
1986
Highly Cited
1986
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)